Literature DB >> 9186067

IgA nephropathy databank: development of a system for management of renal biopsy acquired data.

R J Wyatt1, S N Emancipator, V Kon, F B Waldo, J Donadio, J P Grande, S P Andreoli, R J Glassock.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9186067     DOI： 10.1016/s0272-6386(97)90455-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

1.  The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children.

Authors:  Feng Yu; Jian-Ping Huang; Wan-Zhong Zou; Ming-Hui Zhao
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

2.  Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction.

Authors:  R W Minz; A Bakshi; S Chhabra; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2010-01

3.  Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.

Authors:  Stella Edström Halling; Magnus P Söderberg; Ulla B Berg
Journal:  Pediatr Nephrol       Date:  2008-10-18       Impact factor: 3.714

4.  Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study.

Authors:  James C M Chan; John D Mahan; Howard Trachtman; Jon Scheinman; Joseph T Flynn; Uri S Alon; Marc B Lande; Robert A Weiss; Edward P Norkus
Journal:  Pediatr Nephrol       Date:  2003-08-12       Impact factor: 3.714

5.  Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults.

Authors:  Hoyoung Lee; Sul Hee Yi; Mi Seon Seo; Jin Nam Hyun; Jin Seok Jeon; Hyunjin Noh; Dong Cheol Han; Seung Duk Hwang; So Young Jin; Soon Hyo Kwon
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.